$LGND LIGAND PHARMACEUTICALS INC Insider Trading Week 23/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LIGAND PHARMACEUTICALS INC in week 23/2021.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 08 2021 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 08 2021 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 0.00 | 630 | 0 | 25,061 | 24.4 K to 25.1 K (+2.58 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 630 | 0 | 68,664 | 68 K to 68.7 K (+0.93 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 630 | 0 | 68,664 | 68 K to 68.7 K (+0.93 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 630 | 0 | 3,702 | 3.1 K to 3.7 K (+20.51 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Boyce Sarah | Director | Grant | A | 0.00 | 630 | 0 | 2,892 | 2.3 K to 2.9 K (+27.85 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Gray Nancy Ryan | Director | Grant | A | 0.00 | 630 | 0 | 3,702 | 3.1 K to 3.7 K (+20.51 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 630 | 0 | 28,820 | 28.2 K to 28.8 K (+2.23 %) |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 115.39 | 3,269 | 377,210 | 3,269 | |
Jun 07 2021 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 630 | 0 | 28,820 | 28.2 K to 28.8 K (+2.23 %) |